Arrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $110.2, Implies 23% Upside
Explore more price target data and ratings for Arrowhead Pharmaceuticals, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Arrowhead Pharmaceuticals, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research…